Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 3, 2008
DOI: 10.2337/db08-0170

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db08-0170v1
57/10/2718    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jiang, Y.
Right arrow Articles by Altura, R. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, Y.
Right arrow Articles by Altura, R. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Postnatal expansion of the pancreatic β-cell mass is dependent on survivin

Yuying Jiang, MD/PhD1, Wataru Nishimura, MD/PhD2, Deborah Devor-Henneman, BS3, Donna Kusewitt, DVM/PhD3, Haijuan Wang, PhD4, Michael P. Holloway, PhD1,4, Takehiko Dohi, PhD5, Edmond Sabo, MD6, Michael L. Robinson, PhD7, Dario C. Altieri, MD5, Arun Sharma, PhD2, and Rachel A. Altura, MD1,4

1The Research Institute at Nationwide Children's Hospital, Columbus OH 43205, USA
2Joslin Diabetes Center, Harvard Medical School, Boston MA 02215, USA
3Department of Veterinary Biosciences, The Ohio State University, Columbus OH 43210, USA
4Department of Pediatrics, Brown University, Providence RI 02903, USA
5Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA
6 Department of Pathology and Laboratory Medicine, Brown University, Providence RI 02903, USA
7Department of Zoology, Miami University, Oxford OH 45056, USA

Objective: Diabetes results from a deficiency of functional β-cells due to both an increase in β-cell death and an inhibition of β-cell replication. The molecular mechanisms responsible for these effects in susceptible individuals are mostly unknown. The objective of this study was to determine if a gene critical for cell division and cell survival in cancer cells, survivin, might also be important for β-cells.

Research Design And Methods: We generated mice harboring a conditional deletion of survivin in pancreatic endocrine cells using mice with a Pax-6-Cre transgene promoter construct driving tissue-specific expression of Cre-recombinase in these cells. We performed metabolic studies and immunohistochemical analyses to determine the effects of a mono- and bi-allelic deletion of survivin.

Results: Selective deletion of survivin in pancreatic endocrine cells in the mouse had no discernible effects during embryogenesis, but was associated with striking decreases in β-cell number after birth, leading to hyperglycemia and early-onset diabetes by 4 weeks of age. Serum insulin levels were significantly decreased in animals lacking endocrine cell survivin, with relative stability of other hormones. Exogenous expression of survivin in mature β-cells lacking endogenous survivin completely rescued the hyperglycemic phenotype and the decrease in β-cell mass, confirming the specificity of the survivin effect in these cells.

Conclusions: Our findings implicate survivin in the maintenance of β-cell mass through both replication and anti-apoptotic mechanisms. Given the widespread involvement of survivin in cancer, a novel role for survivin may well be exploited in β-cell regulation in diseased states, such as diabetes.


Correspondence: Rachel_Altura{at}brown.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.